Gordon R. B. Skinner
Corporate Officer/Principal en Vaccine Research International Plc .
Cargos activos de Gordon R. B. Skinner
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
Vaccine Research International Plc
 Vaccine Research International Plc Miscellaneous Commercial ServicesCommercial Services Vaccine Research International Plc is a British company that focuses on conducting clinical trials to evaluate the effectiveness of vaccine SA75 in preventing staphylococcal infections in hospital patients and the wider community. | Corporate Officer/Principal | 09/04/2010 | - |
Historial de carrera de Gordon R. B. Skinner
Antiguos cargos conocidos de Gordon R. B. Skinner.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
HIV-VAC, Inc.
 HIV-VAC, Inc. Miscellaneous Commercial ServicesCommercial Services HIV-VAC, Inc. develops and markets proposed vaccine designed to combat HIV/AIDS. This proposed vaccine, which is called NFU.Ac.HIV, was developed by Dr. Gordon Skinner, director of research, through the University of Birmingham, in the U.K. The proposed vaccine was licensed to Intracell Vaccines Limited from the University of Birmingham. The company was founded in 1997 and is headquartered in Ontario, CA. | Director/Miembro de la Junta | 09/04/2010 | 28/10/2010 |
| Director Técnico/Científico/I+D | 09/04/2010 | 28/10/2010 | |
| GRUPO INTERNATIONAL INC. | Director/Miembro de la Junta | 01/04/1999 | - |
| Director Técnico/Científico/I+D | 01/04/1999 | - | |
Intracell Vaccines Ltd.
 Intracell Vaccines Ltd. Medical SpecialtiesHealth Technology Intracell Vaccines Ltd. develops vaccines. The company is headquartered in Gaithersburg, MD. | Director/Miembro de la Junta | 09/04/2010 | - |
Formación de Gordon R. B. Skinner.
| University of Glasgow | Undergraduate Degree |
| University of Birmingham | Doctorate Degree |
Estadísticas
Internacional
| Reino Unido | 4 |
| Canadá | 3 |
| Estados Unidos | 2 |
Operativa
| Director/Board Member | 3 |
| Chief Tech/Sci/R&D Officer | 2 |
| Doctorate Degree | 2 |
Sectorial
| Commercial Services | 3 |
| Health Technology | 3 |
| Consumer Services | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| GRUPO INTERNATIONAL INC. | Health Technology |
| Empresas privadas | 3 |
|---|---|
HIV-VAC, Inc.
HIV-VAC, Inc. Miscellaneous Commercial ServicesCommercial Services HIV-VAC, Inc. develops and markets proposed vaccine designed to combat HIV/AIDS. This proposed vaccine, which is called NFU.Ac.HIV, was developed by Dr. Gordon Skinner, director of research, through the University of Birmingham, in the U.K. The proposed vaccine was licensed to Intracell Vaccines Limited from the University of Birmingham. The company was founded in 1997 and is headquartered in Ontario, CA. | Commercial Services |
Intracell Vaccines Ltd.
Intracell Vaccines Ltd. Medical SpecialtiesHealth Technology Intracell Vaccines Ltd. develops vaccines. The company is headquartered in Gaithersburg, MD. | Health Technology |
Vaccine Research International Plc
Vaccine Research International Plc Miscellaneous Commercial ServicesCommercial Services Vaccine Research International Plc is a British company that focuses on conducting clinical trials to evaluate the effectiveness of vaccine SA75 in preventing staphylococcal infections in hospital patients and the wider community. | Commercial Services |
- Bolsa de valores
- Insiders
- Gordon R. B. Skinner
- Experiencia